Summit Corp. PLC

Summit Corp. PLC
Stock Exchange Other OTC
EPS
$0.2
Market Cap
-
Shares Outstanding
81.99 M
Public Float
-

Profile

Address
136a Eastern Avenue
Abingdon Oxfordshire OX14 4SB
United Kingdom
Employees -
Website http://summitplc.com
Updated 07/08/2019
Summit Therapeutics Plc is a holding company, which engages in the discovery, development, and commercialization of novel medicines. It focuses on the genetic disease duchenne muscular dystrophy, and the infectious disease clostridium difficile infection. The company was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, United Kingdom.

Financials

View All

Glyn O. Edwards
Chief Executive Officer & Executive Director
Frank Murdoch Armstrong
Non-Executive Chairman